(株)カワチ薬品の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 小売業 | 2664/E03356 | CAWACHI LIMITED |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2014/06/27 | 日証協 | 114,735株 | -1.97% | 2,400株 | -81.01% | 283,250株 | -2.17% | 34,056株 | -82.08% |
| 2014/06/20 | 日証協 | 117,035株 | -1.85% | 12,636株 | +386% | 289,545株 | -1.06% | 190,000株 | +5837.5% |
| 2014/06/13 | 日証協 | 119,235株 | +2.32% | 2,600株 | -65.33% | 292,645株 | +0.62% | 3,200株 | -94.15% |
| 2014/06/06 | 日証協 | 116,535株 | -0.94% | 7,500株 | +7400% | 290,845株 | -0.31% | 54,700株 | +406.48% |
| 2014/05/30 | 日証協 | 117,635株 | 0% | 100株 | 0% | 291,745株 | +3.51% | 10,800株 | +86.21% |
| 2014/05/23 | 日証協 | 117,635株 | -7.18% | 0株 | -100% | 281,845株 | -2.81% | 5,800株 | -94.55% |
| 2014/05/16 | 日証協 | 126,735株 | +29.41% | 31,800株 | +9999.99% | 290,002株 | +23.25% | 106,500株 | +1045.16% |
| 2014/05/09 | 日証協 | 97,935株 | 0% | 200株 | 0% | 235,302株 | -3.45% | 9,300株 | +190.62% |
| 2014/05/02 | 日証協 | 97,935株 | 0% | 0株 | -100% | 243,702株 | +1.04% | 3,200株 | -92.74% |
| 2014/04/25 | 日証協 | 97,935株 | -0.2% | 4,900株 | +2350% | 241,202株 | -0.25% | 44,100株 | +4.75% |
| 2014/04/18 | 日証協 | 98,135株 | +0.1% | 200株 | -99.1% | 241,802株 | +0.61% | 42,100株 | -35.24% |
| 2014/04/11 | 日証協 | 98,035株 | +22.64% | 22,300株 | 0% | 240,345株 | +19.52% | 65,012株 | +80.36% |
| 2014/04/04 | 日証協 | 79,935株 | -5.1% | 0株 | -100% | 201,090株 | +0.35% | 36,045株 | +329.11% |
| 2014/03/28 | 日証協 | 84,235株 | +6.85% | 15,700株 | +67.04% | 200,390株 | -7.61% | 8,400株 | -82.44% |
| 2014/03/20 | 日証協 | 78,835株 | -76.44% | 9,399株 | -91.55% | 216,889株 | -31.95% | 47,846株 | -59.73% |
| 2014/03/14 | 日証協 | 334,655株 | +53.58% | 111,256株 | +1.42% | 318,704株 | +5.25% | 118,804株 | +20.25% |
| 2014/03/07 | 日証協 | 217,899株 | +81.98% | 109,700株 | +32.65% | 302,808株 | +80.41% | 98,800株 | -8.01% |
| 2014/02/28 | 日証協 | 119,735株 | +70.48% | 82,700株 | +127.83% | 167,844株 | +52.11% | 107,400株 | +165.84% |
| 2014/02/21 | 日証協 | 70,235株 | +5.16% | 36,299株 | +640.8% | 110,345株 | +10.96% | 40,400株 | +608.77% |
※株式分割は考慮していませんのでご注意ください。
Page Top